Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

TRADE NEWS: Agilent Technologies and MRM Proteomics Introduce First Commercial Kits for Quality Control of MRM-Based



  TRADE NEWS: Agilent Technologies and MRM Proteomics Introduce First
  Commercial Kits for Quality Control of MRM-Based Quantitative Plasma
  Proteomic Workflows

Business Wire

SANTA CLARA, Calif. & VANCOUVER, British Columbia -- October 9, 2013

Agilent Technologies Inc. (NYSE: A) and MRM Proteomics Inc. today announced
the launch of MRM Proteomics’ PeptiQuant MRM Assay Kits for quality control in
quantitative plasma proteomic analyses based on multiple-reaction monitoring.

MRM Proteomics' PeptiQuant MRM Assay Kits are for quality control in
quantitative plasma proteomic a ...

MRM Proteomics' PeptiQuant MRM Assay Kits are for quality control in
quantitative plasma proteomic analyses based on multiple reaction monitoring.
(Photo: Business Wire)

The two new kits are designed for use on Agilent’s latest-generation
standard-flow UHPLC-QQQ MS/MS platform, which consists of the 1290 Infinity
UHPLC system and the 6490 triple quadrupole mass spectrometer platform.

MRM Proteomics developed the kits to assist in the inter- and intra-laboratory
quality control of MRM experiments in conjunction with stable isotope-labeled
standards:

  * The PeptiQuant LC-MS Platform Performance Kit tests the effectiveness of
    the LC-MS platform.
  * The PeptiQuant Workflow Performance Kit evaluates the performance of an
    entire LC-MRM-MS analytical workflow in human plasma from denaturation
    through digestion to detection.

“Mass spectrometry is becoming increasingly important in biomedical and
biological research, especially with the launch of large-scale initiatives
such as the Human Proteome Project, which depends on mass spectrometry as one
of the main technology platforms,” said Andrew Munk, CEO of MRM Proteomics.
“The mass spec and proteomics communities currently lack standardized
protocols and reagents to ensure high-quality data that can be reproduced by
laboratories across the world using different mass-spec technologies. Our
PeptiQuant™ targeted proteomics Platform and Workflow performance kits will
ensure that high-quality data can be reproduced.”

“Application of QQQ mass spectrometry to protein quantitation is growing
rapidly, and the adoption of this technique will be dependent on robust
protocols that can be used in multiple laboratories,” said Steven Fischer,
director of omics applications for Agilent. “Agilent is pleased to be working
with MRM Proteomics to address this need. PeptiQuant kits from MRM Proteomics,
combined with Agilent’s UHPLC-QQQ MS/MS platform, can be used to ensure
high-quality protein quantification data is being produced in labs around the
world.”

About MRM Proteomics

MRM Proteomics Inc. is a leader in providing advanced protein quantitation,
analytical proteomic services and reagents to the pharmaceutical,
biotechnology and diagnostics industries in key areas such as biomarker
discovery/validation and clinical diagnostics development. Information about
MRM Proteomics is available at www.mrmproteomics.com.

About Agilent Technologies

Agilent Technologies Inc. (NYSE:A) is the world’s premier measurement company
and a technology leader in chemical analysis, life sciences, diagnostics,
electronics and communications. The company’s 20,500 employees serve customers
in more than 100 countries. Agilent had revenues of $6.9 billion in fiscal
2012. Information about Agilent is available at www.agilent.com.

NOTE TO EDITORS: Further technology, corporate citizenship, and executive news
is available on the Agilent news site at www.agilent.com/go/news.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20131009005321/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50725024&lang=en

Contact:

Agilent Technologies
Eric Endicott, + 1 408-553-2005
eric_endicott@agilent.com
or
MRM Proteomics Inc.
Andrew Munk, +1 604-800-2296
munk@mrmproteomics.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement